Pharmacoeconomic Analysis of the Inclusion of Rivaroxaban in the Current Algorithms Prevention of the Stroke in Patients With Atrial Fibrillation

被引：0
|
作者：
Kulikov, A. Yu. [1 ]
Protsenko, M. V. [1 ]
Serdechnaya, E. V. [2 ]
机构：
[1] Sechenov First Moscow State Med Univ, Moscow, Russia
[2] Northern State Med Univ, Arkhangelsk, Russia
来源：
KARDIOLOGIYA | 2016年 / 56卷 / 11期
关键词：
ANTICOAGULATION;
D O I：
10.18565/cardio.2016.11.71-77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：71 / 77
页数：7
相关论文
共 50 条
  • [21] PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION: COST-UTILITY ANALYSIS OF RIVAROXABAN VERSUS WARFARIN IN SLOVAKIA
    Psenkova, M.
    Lukac, M.
    Mackovicova, S.
    Stachova, M.
    Bielik, J.
    Pietsch, G. A.
    Asukai, Y.
    Lloyd, A.
    Evers, T.
    VALUE IN HEALTH, 2012, 15 (07) : A375 - A375
  • [22] BUDGET IMPACT ANALYSIS OF RIVAROXABAN IN THE PREVENTION OF STROKE IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN ITALY
    Capri, S.
    Veneziano, M.
    Ricciardi, W. G.
    D'Ausilio, A.
    Pedone, M. P.
    Bianchi, C.
    VALUE IN HEALTH, 2013, 16 (07) : A519 - A519
  • [23] THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY
    Marmarali, B.
    Ozdemir, O.
    Bozkurt, K.
    Demir, M.
    Ince, B.
    Kultursay, H.
    Ongen, G.
    Ongen, Z.
    Deger, C.
    Ozel, M. O.
    Parali, E.
    Sumer, F.
    Tuna, E.
    Yilmaz, Z. S.
    VALUE IN HEALTH, 2013, 16 (03) : A285 - A285
  • [24] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in Chinese patients with atrial fibrillation
    Mao, Lizheng
    Li, Chengyan
    Li, Tao
    Yuan, Kunxiong
    VASCULAR, 2014, 22 (04) : 252 - 258
  • [25] Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer
    Laube, Eva Simona
    Yu, Anthony
    Gupta, Dipti
    Miao, Yimei
    Samedy, Patrick
    Wills, Jonathan
    Harnicar, Stephen J.
    Soff, Gerald A.
    Mantha, Simon
    BLOOD, 2016, 128 (22)
  • [26] Rivaroxaban: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Carter, Natalie J.
    Plosker, Greg L.
    DRUGS, 2013, 73 (07) : 715 - 739
  • [27] XANTUS, a prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    Postula, Marek
    Kosior, Dariusz
    KARDIOLOGIA POLSKA, 2015, 73 : 71 - 75
  • [28] XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
    Camm, A. John
    Amarenco, Pierre
    Haas, Sylvia
    Hess, Susanne
    Kirchhof, Paulus
    Van Eickels, Martin
    Turpie, Alexander G. G.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 425 - 434
  • [29] Rivaroxaban: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Natalie J. Carter
    Greg L. Plosker
    Drugs, 2013, 73 : 715 - 739
  • [30] Rivaroxaban in the prevention of thromboembolic complications in patients with atrial fibrillation
    Gilyarov, M. Yu.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (03) : 453 - 456
12345